In this study, we showed that autoantibodies of all major Ig subclasses (IgG, IgA, IgM) targeting the SARS-CoV-2 viral host cell receptor ACE2 were present in the blood, and the levels were associated with COVID-19 disease severity. The gene discussed is CD79A; the disease is COVID-19.